Cargando…

Quantitation of Monoclonal Plasma Cells in Bone Marrow Biopsies in Plasma Cell Dyscrasia

Direct measurement of monoclonal plasma cell mass in bone marrow biopsies may be a useful parameter to establish in plasma cell dyscrasia. In this study monoclonal plasma cells/mm(2) in light chain immunoglobulin immunostained archival bone marrow sections from 22 patients in whom a diagnosis of mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markey, G. M., Kettle, P., Morris, T. C. M., Connolly, N., Foster, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2003
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618990/ https://www.ncbi.nlm.nih.gov/pubmed/14501083 http://dx.doi.org/10.1155/2003/821978

Ejemplares similares

Telomerase activity in plasma cell dyscrasias
por: Xu, D, et al.
Publicado: (2001)

Ocular complications of plasma cell dyscrasias
por: Singh, Rohan Bir, et al.
Publicado: (2023)

Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias
por: Roccaro, Aldo M, et al.
Publicado: (2008)

Quantitative and qualitative assessment of plasma cell dyscrasias in dual-layer spectral CT
por: Brandelik, S. C., et al.
Publicado: (2021)

Crusted Scabies in Systemic Sclerosis with Plasma Cell Dyscrasia
por: Nikam, Balkrishna P., et al.
Publicado: (2018)

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
por: Morelli, Eugenio, et al.
Publicado: (2020)

Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia
por: Rajapreyar, Indranee, et al.
Publicado: (2020)

Imaging for Plasma Cell Dyscrasias: What, When, and How?
por: Guha, Amrita, et al.
Publicado: (2022)

Mutational landscape reflects the biological continuum of plasma cell dyscrasias
por: Rossi, A, et al.
Publicado: (2017)

The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
por: Golombick, Terry, et al.
Publicado: (2008)

How I treat elderly patients with plasma cell dyscrasias
por: Gavriatopoulou, Maria, et al.
Publicado: (2018)

A case of plasma cell dyscrasia presenting as nonscarring alopecia
por: Nia, Benjamin, et al.
Publicado: (2021)

Clinical and Biological Characteristics of Medullary and Extramedullary Plasma Cell Dyscrasias
por: Janjetovic, Snjezana, et al.
Publicado: (2021)

Leptomeningeal isolated infiltration in plasma cell dyscrasia associated to HIV
por: Sprenger, Flávia, et al.
Publicado: (2022)

Diagnostic and Therapeutic Considerations in Concurrent Plasma Cell Dyscrasia and Amyloidosis
por: Baljevic, Muhamed
Publicado: (2022)

COVID-19 vaccine immune response and plasma cell dyscrasia
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
por: Sidiqi, M. Hasib, et al.
Publicado: (2020)

The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias
por: Jasiński, Marcin, et al.
Publicado: (2021)

Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias
por: Rebmann Chigrinova, Ekaterina, et al.
Publicado: (2022)

Combination bone marrow imaging using positron emission tomography (PET)-MRI in plasma cell dyscrasias: correlation with prognostic laboratory values and clinicopathological diagnosis
por: Tate, Courtney J, et al.
Publicado: (2019)

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
por: Zambello, Renato, et al.
Publicado: (2020)

Cutaneous Vasculitis: An Unusual Presentation of a Biclonal Nodal Plasma Cell Dyscrasia
por: Swan, D., et al.
Publicado: (2017)

Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers
por: Agarwal, Gaurav, et al.
Publicado: (2022)

C-src Enriched Serum Microvesicles Are Generated in Malignant Plasma Cell Dyscrasia
por: Di Noto, Giuseppe, et al.
Publicado: (2013)

Value of PET-CT in plasma cell dyscrasias: a literature and pictorial review
por: Aggarwal, R, et al.
Publicado: (2015)

Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering
por: Farina, A., et al.
Publicado: (2021)

Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study.
por: Danova, M., et al.
Publicado: (1990)

Coexistence of Plasma Cell Dyscrasia with Prefibrotic Stage of Primary Myelofibrosis: A Case Report
por: Tsirakis, George, et al.
Publicado: (2011)

A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias
por: Lionetti, Marta, et al.
Publicado: (2015)

The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
por: Hemminki, Kari, et al.
Publicado: (2016)

A challenging diagnosis of a nonsecretor plasma cell dyscrasia with pleomorphic plasmablastic morphology
por: Van Landeghem, Stijn, et al.
Publicado: (2020)

COVID-19 Vaccine Responses in Patients With Plasma Cell Dyscrasias After Complete Vaccination
por: Shah, Mansi R., et al.
Publicado: (2022)

Neutrophil Extracellular Traps (NETs) and Hypercoagulability in Plasma Cell Dyscrasias—Is This Phenomenon Worthy of Exploration?
por: Ciepiela, Olga, et al.
Publicado: (2021)

Histiocytic Glomerulopathy With Noncrystalline Inclusion Associated With IgG-Kappa Plasma Cell Dyscrasia
por: Katsuma, Ai, et al.
Publicado: (2023)

The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma
por: Xu, Yanjie, et al.
Publicado: (2023)

Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias
por: Branagan, Andrew R., et al.
Publicado: (2021)

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines
por: Maura, F, et al.
Publicado: (2018)

A Plasma Cell Dyscrasia Presenting as Amyloid Cardiomyopathy and Autonomic Dysfunction in a Healthy Patient
por: Tabet, Rabih, et al.
Publicado: (2017)

Recalcitrant cutaneous pyoderma gangrenosum with pulmonary involvement resolved with treatment of underlying plasma cell dyscrasia
por: Hooton, Tyler A., et al.
Publicado: (2021)

Development of plasma cell dyscrasias in a patient with chronic myeloid leukemia: A case report
por: Zhang, Na, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_74g2p7cl4qtq9np6nq2ju1ricg